Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics
Radiology
Sirona Medical Taps Radiology IT Veteran Ken Kaufman to be CEO in Next Stage of Growth
SAN FRANCISCO, Jan. 28, 2025 /PRNewswire/ — Sirona Medical, a leader in cloud-native radiology workflow solutions, announced the appointment of Ken Kaufman as Chief Executive Officer. Kaufman is a seasoned executive and business builder with a distinguished career spanning radiology and…
Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners
Niagara Falls, NY, Jan. 28, 2025 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to announce sales of the Attrius PET and NeuSight PET-CT 64 slice nuclear imaging systems to a prominent cardiology specialist in the assessment and treatment of cardiovascular disease and interventional cardiovascular services. These cutting-edge technologies are designed to provide unmatched diagnostic precision and value for nuclear cardiology and molecular imaging practices.
Instylla Announces FDA Clearance of Tembo™ Embolic System
BEDFORD, Mass., Jan. 28, 2025 /PRNewswire/ — Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System. The Tembo Embolic System is a bioresorbable1 embolization…
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis
[18F]florbetaben has been granted a Fast Track designation for cardiac amyloidosis, which will expedite the development of [18F]florbetaben for this indication [18F]florbetaben previously received orphan drug status as a diagnostic for the management of AL amyloidosis in EU and US The…
AIRS Medical Partners with Starvision to Bring SwiftMR® MRI Technology to Radiology Practices Throughout Germany
SEOUL, South Korea, Jan. 21, 2025 /PRNewswire/ — AIRS Medical has finalized a landmark agreement with Starvision, a leading radiological practice network in Germany, to bring its advanced MRI reconstruction technology, SwiftMR, to diagnostic imaging practices in Hannover and Munich. This…
NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Osteoarthritis: The U.S. RESORB Trial Launches
SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ — NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for its…
Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters
PLANO, Texas, Jan. 14, 2025 /PRNewswire/ — Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the acquisition of certain assets of Accurate Medical Therapeutics, Ltd.,…
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the publication of the results from the Acute Pulmonary Embolism Extraction Trial with the […]
WindRose Health Investors Makes Strategic Investment in CIVIE
NEW YORK, Jan. 13, 2025 /PRNewswire/ — WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed a strategic investment in CIVIE (“CIVIE” or the “Company”), an AI-powered ecosystem of radiology solutions. The Company’s…